Financhill
Buy
68

ATRA Quote, Financials, Valuation and Earnings

Last price:
$17.59
Seasonality move :
0.8%
Day range:
$16.90 - $18.95
52-week range:
$5.01 - $18.95
Dividend yield:
0%
P/E ratio:
7.93x
P/S ratio:
1.36x
P/B ratio:
--
Volume:
105.6K
Avg. volume:
68.9K
1-year change:
56.67%
Market cap:
$125.3M
Revenue:
$128.9M
EPS (TTM):
$2.19

Earnings Data

Next earnings date for ATRA
Mar 05
2026
Most recent earnings per share
-$0.32
Beat by $0.35
(Nov 12/2025)
Consensus Estimate
-$0.67
(Nov 12/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ATRA Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/05/2026 Q4 $2M -- -- -$0.46 --
11/12/2025 Q3 $2.7M $3.5M -$0.32 -$0.67 $0.35
08/11/2025 Q2 $5.6M $17.6M $0.19 -$0.32 $0.51
05/08/2025 Q1 $4.3M $98.1M $3.50 -$1.93 $5.43
03/07/2025 Q4 $16.6M $32.8M -$1.19 -$3.49 $2.30
11/12/2024 Q3 $35.2M $40.2M -$2.93 -$3.50 $0.56
08/12/2024 Q2 $37.1M $28.6M -$3.10 -$2.24 -$0.86
05/09/2024 Q1 $24.7M $27.4M -$5.65 -$6.42 $0.77
03/28/2024 Q4 $14.3M $4.3M -$13.98 -$12.05 -$1.93
11/01/2023 Q3 $1.3M $2.1M -$16.40 -$16.40 $0.00
08/08/2023 Q2 -- $957K -$0.68 -- --
05/08/2023 Q1 -- $1.2M -$0.72 -- --
02/08/2023 Q4 -- $221K -$0.72 -- --
11/08/2022 Q3 -- $4.5M -$0.82 -- --
08/08/2022 Q2 -- $51.6M $0.18 -- --
05/05/2022 Q1 -- $7.3M -$0.87 -- --
02/28/2022 Q4 -- $7.5M -$0.96 -- --
11/04/2021 Q3 -- $5.4M -$0.90 -- --
08/09/2021 Q2 -- $3.9M -$0.91 -- --
05/04/2021 Q1 -- $3.6M -$0.86 -- --
03/01/2021 Q4 -- -- -$0.95 -- --
11/09/2020 Q3 -- -- -$0.92 -- --
08/05/2020 Q2 -- -- -$1.14 -- --
05/06/2020 Q1 -- -- -$1.20 -- --
02/27/2020 Q4 -- -- -$1.36 -- --
11/07/2019 Q3 -- -- -$1.31 -- --
08/08/2019 Q2 -- -- -$1.60 -- --
05/09/2019 Q1 -- -- -$1.44 -- --
02/26/2019 Q4 -- -- -$43.70 -- --
11/06/2018 Q3 -- -- -$32.13 -- --
08/01/2018 Q2 -- -- -$28.66 -- --
05/08/2018 Q1 -- -- -$26.17 -- --
02/27/2018 Q4 -- -- -$28.80 -- --
11/09/2017 Q3 -- -- -$25.51 -- --
08/07/2017 Q2 -- -- -$23.45 -- --
05/04/2017 Q1 -- -- -$22.07 -- --
03/09/2017 Q4 -- -- -$15.75 -- --
11/04/2016 Q3 -- -- -$22.00 -- --
08/08/2016 Q2 -- -- -$16.50 -- --
05/05/2016 Q1 -- -- -$14.50 -- --
03/03/2016 Q4 -- -- -$18.75 -- --

Atara Biotherapeutics, Inc. Earnings Questions

  • How Much did Atara Biotherapeutics, Inc. Generate in Revenue Last Quarter?

    Atara Biotherapeutics, Inc. reported $3.5M worth of top line sales in its most recent quarter.

  • Did Atara Biotherapeutics, Inc. Beat Earnings Last Quarter?

    Atara Biotherapeutics, Inc. announced earnings per share of -$0.32 which represents a beat of analyst forecast a -$0.67 per share.

  • Is Atara Biotherapeutics, Inc. Profitable?

    Atara Biotherapeutics, Inc. reported $3.3M that represents $0.25 per share over the last quarter.

  • What is the Analyst Consensus for Atara Biotherapeutics, Inc. EPS Next Year?

    Atara Biotherapeutics, Inc.'s earnings are forecast to decrease from -$11.41 per share to -$1.64 per share next year representing a decrease of -49.1%.

  • When is Atara Biotherapeutics, Inc.'s Earnings Date?

    Atara Biotherapeutics, Inc.'s next earnings date is March 5, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
60
AAOI alert for Dec 24

Applied Optoelectronics, Inc. [AAOI] is up 5.1% over the past day.

Buy
85
HUT alert for Dec 24

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
63
GPCR alert for Dec 24

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock